The implementation of lifelong antiretroviral treatment (ART) for all pregnant women (Option B
Explore Related Resources
Poster
Twenty-Four-Month Survival Among Patients with Cryptococcal Antigenemia Enrolled in Malawi’s Advanced HIV Disease Program: A Retrospective Cohort Study
Published August 2026
We assessed 24-month survival and factors associated with mortality among AHD clients with cryptococcal antigenemia enrolled in Malawi’s AHD program.
Topics:
Advanced HIV Disease (AHD)
Countries:
Malawi
Resource
Evidence for sustainable parenting and cash transfer programmes in Tanzania
Published June 2026
In Tanzania’s Dodoma region, EGPAF partnered on Kizazi Kijacho — meaning “Next Generation” in Swahili — a large-scale randomized controlled trial testing whether parenting support, cash transfers, or both could improve early childhood development outcomes across more than 3,100 families. The findings have direct implications for how governments design scalable, affordable ECD programs. Parenting support […]
Topics:
Children,
Maternal and Child Health
Countries:
Tanzania
Journal Articles
Clinical Impact and Cost-Effectiveness of Improving Access to Cryptococcal Meningitis Diagnostics and Treatment in Malawi
Published May 2026
Abstract Background Cryptococcal meningitis (CM) causes 13%–20% of deaths among people living with HIV (PLHIV) globally. We examined the cost-effectiveness of improving access to CM diagnostics and treatment among PLHIV initiating HIV care with a positive serum cryptococcal antigen (CrAg) test in Malawi. Methods We used the CEPAC-I model to simulate (1) Current care (CM treatment if […]
Topics:
HIV
Countries:
Malawi